1 / 40

Cardiovascular Outcomes Trials in Diabetes: The Truth, the Whole Truth, and Nothing But the Truth

Cardiovascular Outcomes Trials in Diabetes: The Truth, the Whole Truth, and Nothing But the Truth. Program Goals. The Growing Diabetes Pandemic. Approved Antidiabetic Medications. Cardiovascular benefits to tighter HbA 1c control?.

graham
Download Presentation

Cardiovascular Outcomes Trials in Diabetes: The Truth, the Whole Truth, and Nothing But the Truth

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Cardiovascular Outcomes Trials in Diabetes: The Truth, the Whole Truth, and Nothing But the Truth

  2. Program Goals

  3. The Growing Diabetes Pandemic

  4. Approved Antidiabetic Medications

  5. Cardiovascular benefits to tighter HbA1c control?

  6. Outcomes of Better Glycemic Control in T2D: UKPDS and Post-UKPDS

  7. Should Hyperglycemia in Diabetes Be Treated Aggressively?

  8. DCCT/EDIC: Intensive Diabetes Therapy in T1D

  9. Counseling a Patient With Newly Diagnosed T2D

  10. Sulfonylureas

  11. Safety of Sulfonylureas

  12. Safety of Sulfonylureas (cont)

  13. The CAROLINA Study: Phase 3 Results

  14. Rosiglitazone Data Reanalyzed

  15. Results of a Reevaluation of Cardiovascular Outcomes in the RECORD Trial

  16. Thiazolidinediones

  17. Pioglitazone: The PROactive Study

  18. Guidance for Industry: Diabetes Mellitus -- Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat T2D

  19. Impact of FDA Guidance: December 2008

  20. Incretin-Based Drugs

  21. Incretin-Based Drugs (cont)

  22. Warnings and Precautions

  23. SGLT-2 Inhibitors

  24. SGLT-2 Inhibitors (cont)

  25. SAVOR-TIMI 53 trial

  26. Take-Home Messages

  27. Abbreviations

  28. Abbreviations (cont)

  29. Abbreviations (cont)

  30. References

  31. References (cont)

  32. References (cont)

  33. References (cont)

  34. References (cont)

  35. References (cont)

  36. References (cont)

  37. References (cont)

More Related